Filed: 8/14/2025ACC: 0000904454-25-000424
📋 What this filing means
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $690.91M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$690.91M
Total AUM (reported)
2.16M
Total Shares
Allocation by class
TR UNIT$687.43M99.5%
COM$2.66M0.4%
CL A$824.6K0.1%
*W EXP 08/01/2$600.000.0%
Portfolio Concentration
Top 3$689.79M99.8%
4–10$1.13M0.2%
Top 3 weight
99.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.16M
Sole
Full voting authority
2.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings9
Rows:
SPDR S&P 500 ETF TR
SOLEShares1.11M
TypeSH
Market value$687.43M
99.50%
Sole
1.11M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares192.97K
TypeSH
Market value$1.53M
0.22%
Sole
192.97K
Shared
0.00
None
0.00
HEICO CORP NEW
SOLEShares3.19K
TypeSH
Market value$824.6K
0.12%
Sole
3.19K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares47.93K
TypeSH
Market value$428.5K
0.06%
Sole
47.93K
Shared
0.00
None
0.00
Q32 BIO INC
SOLEShares133.90K
TypeSH
Market value$199.5K
0.03%
Sole
133.90K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares291.83K
TypeSH
Market value$178.3K
0.03%
Sole
291.83K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares249.63K
TypeSH
Market value$169.8K
0.02%
Sole
249.63K
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares91.91K
TypeSH
Market value$148.9K
0.02%
Sole
91.91K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares33.33K
TypeSH
Market value$600.00
<0.01%
Sole
33.33K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.11M | SH | $687.43M 99.50% | 1.11M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 192.97K | SH | $1.53M 0.22% | 192.97K | 0.00 | 0.00 |
HEICO CORP NEWSOLE | CL A | 3.19K | SH | $824.6K 0.12% | 3.19K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM | 47.93K | SH | $428.5K 0.06% | 47.93K | 0.00 | 0.00 |
Q32 BIO INCSOLE | COM | 133.90K | SH | $199.5K 0.03% | 133.90K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 291.83K | SH | $178.3K 0.03% | 291.83K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 249.63K | SH | $169.8K 0.02% | 249.63K | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 91.91K | SH | $148.9K 0.02% | 91.91K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/2 | 33.33K | SH | $600.00 <0.01% | 33.33K | 0.00 | 0.00 |